Dermapharm Holding SE Logo

Dermapharm Holding SE

DMP | F

Overview

Corporate Details

ISIN(s):
DE000A2GS5D8
LEI:
5299009F0KNZINQQQK37
Country:
Germany
Address:
Lil-Dagover-Ring 7, 82031 Grünwald
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dermapharm Holding SE is a German manufacturer of branded pharmaceuticals and healthcare products, founded in 1991. The company specializes in patent-free branded medicines, over-the-counter (OTC) products, and herbal food supplements, with a particular focus on dermatological and allergological preparations. Dermapharm operates an integrated business model that includes in-house research and development, production, and distribution through its own pharmaceutical sales force. It targets selected profitable niche markets and pursues growth through a combination of organic development, supported by a pipeline of over 60 projects, and a successful acquisition strategy to expand its international presence, primarily in Europe.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Dermapharm Holding SE and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 07:30
Earnings Release
Dermapharm confirms stable business development in H1 2025 and records EBITDA g…
English 25.4 KB
2025-08-26 00:00
Interim Report
Half-yearly financial report 2025
English 1.5 MB
2025-08-18 09:26
Report Publication Announcement
English 4.0 KB
2025-08-12 07:30
Earnings Release
Dermapharm Holding SE remains on projected growth trajectory in Q2 2025
English 15.1 KB
2025-07-04 16:18
Director's Dealing
Dermapharm Holding SE: Wilhelm Beier, buy
English 5.8 KB
2025-07-01 12:30
Declaration of Voting Results & Voting Rights Announcements
German 12.3 KB
2025-06-27 14:40
Declaration of Voting Results & Voting Rights Announcements
English 12.0 KB
2025-06-26 17:43
Post-Annual General Meeting Information
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of…
English 10.9 KB
2025-06-24 16:46
Director's Dealing
Dermapharm Holding SE: Dr. Andreas Eberhorn, buy
English 5.8 KB
2025-06-05 12:29
Director's Dealing
Dermapharm Holding SE: Anja Schorn, buy
English 6.2 KB
2025-06-04 11:19
Director's Dealing
Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy
English 6.9 KB
2025-05-16 15:05
Pre-Annual General Meeting Information
Dermapharm Holding SE: Bekanntmachung der Einberufung zur Hauptversammlung am 2…
German 59.4 KB
2025-05-15 07:30
Earnings Release
Dermapharm Holding SE performs in line with projections in Q1 2025, confirms fu…
English 23.6 KB
2025-05-15 00:00
Interim Report
Q1 statement / Q1 financial report 2025
English 347.5 KB
2025-05-07 08:40
Report Publication Announcement
English 3.9 KB

Automate Your Workflow. Get a real-time feed of all Dermapharm Holding SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Dermapharm Holding SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-12-30 Themis Beteiligungs-Aktiengesellschaft Close relation Buy None 54,530,000.00 EUR
2024-12-30 Beier, Wilhelm Supervisory board Buy None 3,895,000.00 EUR
2024-11-15 Themis Beteiligungs-Aktiengesellschaft Close relation Buy None 6,464,000.00 EUR
2024-11-11 Feldmeier, Dr. Hans-Georg Board Buy None 95,185.00 EUR
2024-11-05 Dreibholz, Christof Board Buy None 27,720.00 EUR
2024-10-23 Lanz, Susanne Gertrud Pia Close relation Buy None 19,704.55 EUR
2024-08-29 Themis Beteiligungs-Aktiengesellschaft Close relation Buy None 29,954,600.00 EUR
2024-06-11 Lanz, Susanne Gertrud Pia Close relation Buy None 101,778.57 EUR
2024-05-22 Themis Beteiligungs-Aktiengesellschaft Close relation Buy None 8,577,500.00 EUR
2023-06-27 Feldmeier, Dr. Hans-Georg Board Buy None 99,902.36 EUR

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.